TMO Trading Analysis - 10/23/2026 01:17 PM — TRU-SENTIMENT

News Headlines & Context

Recent general-knowledge context for Thermo Fisher Scientific (TMO) includes the following thematic headlines and events that may shape trader bias:

• TMO reported steady lab-equipment demand recovery in early 2026, supported by academic and biopharma spending normalization.
• Management highlighted margin expansion initiatives ahead of the Q4 2026 earnings cycle (fiscal year end was 2025-12-01 per data).
• Healthcare-sector rotation into large-cap defensives with low beta (TMO beta 0.71) has improved relative strength vs broader indices.
• No major negative regulatory action disclosed in public tone; supply-chain stabilization cited as a positive catalyst.
• Context: The bullish options flow and rising daily closes through Oct 21 align with constructive sector sentiment, though Oct 22 pullback shows caution.

Fundamental Analysis

Based strictly on the provided FUNDAMENTALS data for TMO:

• Trailing P/E is 36.90 and Trailing EPS is 18.61; forward P/E, PEG, and price/book are null (not available in data).
• Market Cap is 250,939,893,960.00 with shares outstanding of 369,747,000.00.
• Dividend Yield is 0.27% with dividend rate 1.88 and ex-dividend date 2026-09-15.
• Beta is 0.71 (low volatility relative to market); 52-week high 705.79, low 435.27.
• Institutional ownership is 66.21%; average volume 2,370,000.00; historical volatility 26.75%.
• Revenue growth, margins, ROE, debt/equity, and free cash flow are null in data — cannot be assessed.
• Analyst target mean and recommendation key are null — no consensus target available.
• Fundamentals show stable large-cap profile with low beta; aligns with technical uptrend but lacks margin data to confirm earnings quality.

Current Market Position

Current price per indicators is 678.68 (2026-10-22 close). Recent daily action: Sep 11 close 609.82 → Oct 21 close 696.78 (high 705.79) → Oct 22 close 678.68 on volume 2,529,613.00. Minute bars for 2026-10-22 show open 691.70, high 703.20, low 674.10, close 675.81 at 15:55; late-session weakness with last 5 bars drifting from 676.42 to 675.81 on rising volume (198,873.00 at final bar).

Technical Analysis

SMA alignment: 5-day (686.95) > 20-day (672.73) > 50-day (643.66) — bullish stack, no bearish crossover. RSI 58.04 shows moderate bullish momentum, not overbought. MACD histogram +2.58 (12.88 minus 10.30) confirms positive momentum. Bollinger Bands: middle 672.73, upper 701.00, lower 644.47 — price 678.68 sits just above middle, no squeeze (bands wide). 30-day range high 705.78, low 605.65; price is ~60% up the range.

True Sentiment Analysis (Delta 40-60 Options)

Options flow via True Sentiment (delta 40-60 only):

Call Volume: $1,870,700.00 (84.20%) Put Volume: $350,240.00 (15.80%) Total: $2,220,940.00

Sentiment is Bullish. Call contracts 375 vs put 105; call trades 20 vs put 22 (fewer call trades but larger size). Pure directional conviction strongly favors calls. No divergence from technical uptrend; both support higher bias.

Key Price Levels (Observational Only)